Effectiveness of bivalent COVID-19 boosters against COVID-19 mortality in people aged 65 years and older, Australia, November 2022 to May 2023

We followed 4,081,257 Australian adults aged ≥ 65 years between November 2022 and May 2023 for COVID-19-specific mortality, when recombinant SARS-CoV-2 Omicron lineages (predominantly XB and XBB) as well as BA.2.75 were circulating. Compared with a COVID-19 booster targeting ancestral SARS-CoV-2 giv...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Bette, Stepien, Sandrine, Sharma, Ketaki, Macartney, Kristine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Centre for Disease Prevention and Control (ECDC) 2023
Materias:
Rapid Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668254/
https://www.ncbi.nlm.nih.gov/pubmed/37997663
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.47.2300603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10668254/
https://www.ncbi.nlm.nih.gov/pubmed/37997663
http://dx.doi.org/10.2807/1560-7917.ES.2023.28.47.2300603

Ejemplares similares